[Therapy of meningitides].
D000367:Age Factors; D000666:Amphotericin B / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003454:Cryptococcus; D004927:Escherichia coli Infections; D006801:Humans; D007275:Injections, Intravenous; D007278:Injections, Spinal; D007427:Intracranial Pressure; D007919:Leptospira; D008581:Meningitis / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008584:Meningitis, Listeria / Q000188:drug therapy; D008585:Meningitis, Meningococcal / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D008587:Meningitis, Viral / Q000628:therapy; D008826:Microbial Sensitivity Tests; D010406:Penicillins / Q000627:therapeutic use; D013203:Staphylococcal Infections; D013290:Streptococcal Infections; D013307:Streptomycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D010406:Penicillins; D013449:Sulfonamides; D000666:Amphotericin B; D013307:Streptomycin
Therapie der Meningtiden.